Method for treating metabolic disorders by administration of an anti-ActRIIB antibody
US9365651B2 · kind B2 · utility
3Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2012 |
| Grant date | Jun 14, 2016 |
| Priority date | — |
| Expiry date | Jun 29, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions comprising anti-ActRIIB antibodies and use thereof for increasing brown fat in vertebrate, including rodents and primates, and particularly in humans without significantly affecting hematological parameters.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.